In the present study, we found that IFNα treatment alone promoted the generation of erythroid cells in both RPS19-reduced primary erythroid cells and BM cells collected from DBA patients, whose erythroid cells were differentiated ex vivo. The gene discussed is RPS19; the disease is Diamond-Blackfan anemia.